Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Role of mpMRI in the Assessment of Prostate Cancer Recurrence Using the PI-RR System: Diagnostic Accuracy and Interobserver Agreement in Readers with Different Expertise.
Bergaglio C, Giasotto V, Marcenaro M, Barra S, Turazzi M, Bauckneht M, Casaleggio A, Sciabà F, Terrone C, Mantica G, Borghesi M, Signori A, Spina B, Piol N, Zanardi E, Fornarini G, Zawaideh JP; Uro-Oncology Disease Management Team (DMT) of the IRCCS Ospedale Policlinico San Martino Genoa, Italy. Bergaglio C, et al. Among authors: signori a. Diagnostics (Basel). 2023 Jan 20;13(3):387. doi: 10.3390/diagnostics13030387. Diagnostics (Basel). 2023. PMID: 36766492 Free PMC article.
The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study.
Bauckneht M, Rebuzzi SE, Signori A, Donegani MI, Murianni V, Miceli A, Borea R, Raffa S, Damassi A, Ponzano M, Catalano F, Martelli V, Marini C, Boccardo F, Morbelli S, Sambuceti G, Fornarini G. Bauckneht M, et al. Among authors: signori a. Cancers (Basel). 2020 Oct 31;12(11):3213. doi: 10.3390/cancers12113213. Cancers (Basel). 2020. PMID: 33142739 Free PMC article.
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study).
Bauckneht M, Rebuzzi SE, Signori A, Frantellizzi V, Murianni V, Lodi Rizzini E, Mascia M, Lavelli V, Donegani MI, Ponzano M, Gaudiano A, Stazza ML, Licari M, Cavallini L, Laghi V, Cindolo L, Maggi M, Sciarra A, Mammucci P, Sambuceti G, Costa RP, Spanu A, Rubini G, Monari F, De Vincentis G, Fornarini G. Bauckneht M, et al. Among authors: signori a. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1063-1074. doi: 10.1007/s00259-021-05550-6. Epub 2021 Sep 6. Eur J Nucl Med Mol Imaging. 2022. PMID: 34486070 Free PMC article.
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
Rebuzzi SE, Cerbone L, Signori A, Santoni M, Murianni V, De Giorgi U, Procopio G, Porta C, Milella M, Basso U, Massari F, Maruzzo M, Iacovelli R, Battelli N, Carmisciano L, Banna GL, Buti S, Fornarini G. Rebuzzi SE, et al. Among authors: signori a. Ther Adv Med Oncol. 2022 Feb 26;14:17588359221079580. doi: 10.1177/17588359221079580. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35237353 Free PMC article.
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives.
Rebuzzi SE, Rescigno P, Catalano F, Mollica V, Vogl UM, Marandino L, Massari F, Pereira Mestre R, Zanardi E, Signori A, Buti S, Bauckneht M, Gillessen S, Banna GL, Fornarini G. Rebuzzi SE, et al. Among authors: signori a. Cancers (Basel). 2022 Feb 28;14(5):1245. doi: 10.3390/cancers14051245. Cancers (Basel). 2022. PMID: 35267553 Free PMC article. Review.
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study.
Bauckneht M, Rebuzzi SE, Ponzano M, Borea R, Signori A, Frantellizzi V, Lodi Rizzini E, Mascia M, Lavelli V, Miceli A, De Feo MS, Pisani AR, Nuvoli S, Tripoli V, Morganti AG, Mammucci P, Caponnetto S, Mantica G, Di Nicola AD, Villano C, Cindolo L, Morbelli S, Sambuceti G, Fanti S, Costa RP, Spanu A, Rubini G, Monari F, De Vincentis G, Fornarini G. Bauckneht M, et al. Among authors: signori a. Cancers (Basel). 2022 Mar 29;14(7):1744. doi: 10.3390/cancers14071744. Cancers (Basel). 2022. PMID: 35406515 Free PMC article.
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia.
Giacobbe DR, Mora S, Signori A, Russo C, Brucci G, Campi C, Guastavino S, Marelli C, Limongelli A, Vena A, Mikulska M, Marchese A, Di Biagio A, Giacomini M, Bassetti M. Giacobbe DR, et al. Among authors: signori a. Diagnostics (Basel). 2023 Mar 3;13(5):961. doi: 10.3390/diagnostics13050961. Diagnostics (Basel). 2023. PMID: 36900105 Free PMC article.
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Rebuzzi SE, Brunelli M, Galuppini F, Vellone VG, Signori A, Catalano F, Damassi A, Gaggero G, Rescigno P, Maruzzo M, Merler S, Vignani F, Cavo A, Basso U, Milella M, Panepinto O, Mencoboni M, Sbaraglia M, Dei Tos AP, Murianni V, Cremante M, Llaja Obispo MA, Maffezzoli M, Banna GL, Buti S, Fornarini G. Rebuzzi SE, et al. Among authors: signori a. Cancers (Basel). 2023 Apr 21;15(8):2394. doi: 10.3390/cancers15082394. Cancers (Basel). 2023. PMID: 37190322 Free PMC article.
299 results